Ancient herbal formula put to the test against diabetic kidney disease

NCT ID NCT07698223

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This trial investigates whether adding Naoxintong Capsule, a traditional Chinese medicine made from 16 herbal and animal ingredients, to standard therapy can slow the progression of diabetic nephropathy in people with type 2 diabetes. The study involves 410 participants who will receive either the capsule or a placebo for 12 months. The main goal is to measure the annual rate of kidney function decline, along with other kidney and heart health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Naoxintong Capsule (a blend of 16 herbal and animal ingredients)
What this could lead to
If effective, this could offer a new add-on therapy to slow kidney decline and reduce cardiovascular risk in people with diabetic nephropathy.
What could go wrong
This is a Phase 4 trial with a moderate sample size. The herbal mixture is complex, and results may not generalize beyond the studied population. Side effects from the multiple ingredients are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • China-Japan Friendship Hospital

    Beijing, Beijing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chinese PLA General Hospital, First Medical Center

    Beijing, Beijing Municipality, 100853, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Daping Hospital, Army Medical University

    Chongqing, Chongqing Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • First Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Longhua Hospital, Shanghai University of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Renji Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhejiang Provincial Hospital of Traditional Chinese Medicine

    Hangzhou, Zhejiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.